News

BioData provides a lab management solution and allows the researchers to monitor materials, projects and experiments easily. LabLife was founded by Melina Fan, Benjie Chen and Kenneth Fan

As per the deal, both the firms will work together for identifying and characterizing biomarkers for drug development, drug discovery and diagnostics applications for range of therapeutic areas.

The filing of the NDA is backed by the results from a multicenter, two-cohort, single-arm, open-label Phase II Erivance BCC study that investigated vismodegib in patients with advanced

Esbriet is an orally active drug that inhibits the synthesis of TGF-beta, a chemical mediator that controls many cell functions including proliferation and differentiation, and plays a key

Using its proprietary antibody discovery platforms, Humabs is focused on the discovery and development of next-generation fully human monoclonal antibodies targeted at infectious and inflammatory diseases. The technologies

The grant permits Diamyd to develop NTDDS-based drug candidate designed to deliver a neurotrophic factor to nerve cells. Neurotrophic factors are a class of small proteins which promote

Ceplene is administered with interleukin-2 (IL-2) for the remission maintenance and prevention of relapse of patients with acute myeloid leukemia (AML) in first complete remission. The FDA indicated

Ark will work with PsiOxus in providing oncolytic adenoviral material for IV administration in toxicological and Phase I/II clinical studies, using Ark’s suspension based single use system (ATOSUS).

Silence is currently conducting a Phase I trial with Atu027 in patients with advanced solid cancer. Interim data analysis from this trial showed that Atu027 is safe and